|
humans |
19 |
|
covid-19 |
18 |
|
coronavirus |
16 |
|
sars-cov-2 |
16 |
|
transmission |
15 |
|
animals |
14 |
|
child |
14 |
|
genome, viral |
14 |
|
adult |
13 |
|
china |
13 |
|
influenza, human - virology |
13 |
|
molecular sequence data |
13 |
|
rhizopus microsporus |
13 |
|
sequence analysis, dna |
13 |
|
species index: fungi |
13 |
|
animal |
12 |
|
male |
12 |
|
phylogeny |
12 |
|
reverse transcriptase polymerase chain reaction |
12 |
|
amino acid sequence |
11 |
|
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
|
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
|
enzyme-linked immunosorbent assay |
11 |
|
nucleocapsid proteins - genetics - immunology |
11 |
|
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
|
severe acute respiratory syndrome - drug therapy |
11 |
|
temperature |
11 |
|
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
|
age |
10 |
|
base sequence |
10 |
|
birds - virology |
10 |
|
cell line |
10 |
|
cell line, tumor |
10 |
|
cell tropism |
10 |
|
chick embryo |
10 |
|
china - epidemiology |
10 |
|
coronavirus - genetics - isolation & purification |
10 |
|
damplicon |
10 |
|
disease outbreaks |
10 |
|
dogs |
10 |
|
female |
10 |
|
h5n1 |
10 |
|
immune response |
10 |
|
influenza a virus, h1n1 subtype - physiology |
10 |
|
influenza a virus, h5n1 subtype - physiology |
10 |
|
influenza h1n1 |
10 |
|
influenza in birds - virology |
10 |
|
swine - virology |
10 |
|
swine diseases - virology |
10 |
|
swine-origin |
10 |
|
viral load |
10 |
|
virus replication |
10 |
|
5' untranslated regions |
9 |
|
amino acid substitution |
9 |
|
blood donors |
9 |
|
blotting, western |
9 |
|
coronavirus - classification - genetics |
9 |
|
cross infection - epidemiology - immunology |
9 |
|
disease reservoirs - virology |
9 |
|
dogs - virology |
9 |
|
genotype |
9 |
|
immunoglobulin g - analysis - immunology |
9 |
|
membrane glycoproteins - analysis |
9 |
|
picornaviridae - chemistry - classification - genetics - isolation and purification |
9 |
|
pneumonia, viral - epidemiology - immunology - virology |
9 |
|
pneumonia, viral - virology |
9 |
|
recombinant proteins - analysis - immunology |
9 |
|
ribosomes - genetics - metabolism |
9 |
|
seroepidemiologic studies |
9 |
|
severe acute respiratory syndrome - epidemiology - immunology - virology |
9 |
|
viral envelope proteins - analysis |
9 |
|
bat |
8 |
|
chiroptera - virology |
8 |
|
coronavirus - classification - genetics - isolation & purification |
8 |
|
coronavirus infections - epidemiology - physiopathology - virology |
8 |
|
delns1-ncov-rbd laiv |
8 |
|
intranasal |
8 |
|
novel |
8 |
|
phase-1 |
8 |
|
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
|
seizures, febrile - epidemiology |
8 |
|
acute disease |
7 |
|
administration, oral |
7 |
|
antibodies, viral - blood |
7 |
|
bocavirus - classification - genetics - isolation and purification |
7 |
|
cattle - virology |
7 |
|
cattle diseases - virology |
7 |
|
chemicals and cas registry numbers |
7 |
|
child, preschool |
7 |
|
cluster analysis |
7 |
|
community-acquired-infections-epidemiology |
7 |
|
community-acquired-infections-mortality |
7 |
|
community-acquired-infections-physiopathology |
7 |
|
community-acquired-infections-virology |
7 |
|
coronavirus-genetics |
7 |
|
genome |
7 |
|
genomics |
7 |
|
hemagglutinins - genetics |
7 |
|
hong kong |
7 |
|
hong kong - epidemiology |
7 |
|
immunization schedule |
7 |
|
immunology |
7 |
|
infant |
7 |
|
infant, newborn |
7 |
|
influenza a virus, h1n1 subtype - genetics |
7 |
|
influenza, human - epidemiology - virology |
7 |
|
injections, intraperitoneal |
7 |
|
membrane glycoproteins - genetics - immunology |
7 |
|
mice |
7 |
|
mice, inbred balb c |
7 |
|
multigene family |
7 |
|
nucleocapsid - analysis |
7 |
|
parvoviridae infections - veterinary - virology |
7 |
|
parvovirinae - classification - genetics - isolation and purification |
7 |
|
parvovirus - classification - genetics - isolation and purification |
7 |
|
parvovirus - genetics - isolation and purification |
7 |
|
reproducibility of results |
7 |
|
respiratory tract infections - virology |
7 |
|
rhinovirus - classification - genetics |
7 |
|
sars virus - chemistry |
7 |
|
sars virus - classification - genetics - isolation & purification |
7 |
|
sars virus - immunology |
7 |
|
severe acute respiratory syndrome - diagnosis |
7 |
|
severe acute respiratory syndrome - diagnosis - virology |
7 |
|
sheep - virology |
7 |
|
vaccines, dna - administration & dosage - immunology |
7 |
|
viral envelope proteins - genetics - immunology |
7 |
|
viral proteins - blood - genetics |
7 |
|
viral proteins - genetics |
7 |
|
virology |
7 |
|
3' untranslated regions |
6 |
|
amino acid substitution - genetics |
6 |
|
antibodies, viral - blood - immunology |
6 |
|
antibody specificity |
6 |
|
bacterial vaccines - administration & dosage - immunology |
6 |
|
bird diseases - epidemiology - virology |
6 |
|
coronaviridae - classification - genetics - isolation & purification |
6 |
|
coronavirus infections - genetics |
6 |
|
crossing over, genetic |
6 |
|
diagnostic |
6 |
|
diverse |
6 |
|
emerging |
6 |
|
enterovirus a, human - classification - genetics - isolation & purification |
6 |
|
epidemiology |
6 |
|
escherichia coli proteins |
6 |
|
genes, viral/ - genetics |
6 |
|
hand, foot and mouth disease - epidemiology - virology |
6 |
|
hemagglutinins, viral - metabolism |
6 |
|
immunization, secondary |
6 |
|
immunoglobulin g - blood |
6 |
|
influenza a virus, h1n1 subtype - metabolism |
6 |
|
injections, intramuscular |
6 |
|
interferon-gamma - analysis |
6 |
|
interleukin-4 - analysis |
6 |
|
interspecies |
6 |
|
liver disease |
6 |
|
membrane glycoproteins - administration & dosage - genetics - immunology |
6 |
|
models, animal |
6 |
|
molecular epidemiology |
6 |
|
multigene family - genetics |
6 |
|
neutralization tests |
6 |
|
nucleic acid conformation |
6 |
|
nucleocapsid proteins - immunology |
6 |
|
open reading frames - genetics |
6 |
|
paramyxoviridae - classification - genetics - isolation & purification |
6 |
|
paramyxoviridae infections - veterinary - virology |
6 |
|
paramyxovirus |
6 |
|
parvovirus |
6 |
|
pcr |
6 |
|
picornaviridae - classification - genetics - isolation & purification |
6 |
|
pneumonia - etiology |
6 |
|
polymorphism, genetic |
6 |
|
public health |
6 |
|
recombination, genetic |
6 |
|
rna, viral - chemistry |
6 |
|
rna, viral - genetics |
6 |
|
rodent |
6 |
|
seasons |
6 |
|
sequence alignment |
6 |
|
sequence homology, amino acid |
6 |
|
severe acute respiratory syndrome - complications - immunology |
6 |
|
severe acute respiratory syndrome - diagnosis - immunology |
6 |
|
severe acute respiratory syndrome - prevention & control |
6 |
|
songbirds - virology |
6 |
|
species specificity |
6 |
|
tuhokovirus |
6 |
|
vaccines, synthetic - administration & dosage - immunology |
6 |
|
viral envelope proteins - administration & dosage - genetics - immunology |
6 |
|
viral structural proteins - genetics |
6 |
|
viremia - diagnosis - epidemiology |
6 |
|
zoonosis |
6 |
|
3c-like protease |
5 |
|
aged |
5 |
|
aged, 80 and over |
5 |
|
antibodies, monoclonal - immunology |
5 |
|
antigens, viral, tumor - genetics - immunology |
5 |
|
astroviridae - classification - genetics - isolation and purification |
5 |
|
astroviridae infections - veterinary - virology |
5 |
|
b.1.1.7b.1.351 |
5 |
|
bacteremia - microbiology |
5 |
|
bacterial typing techniques |
5 |
|
bats |
5 |
|
beta-lactamases - chemistry - genetics |
5 |
|
bk virus - genetics - immunology - pathogenicity |
5 |
|
bk virus nephropathy |
5 |
|
bocaparvovirus |
5 |
|
campylobacter fetus - classification - genetics - growth & development - isolation & purification |
5 |
|
campylobacter infections - microbiology |
5 |
|
cattle |
5 |
|
communicable diseases, emerging - microbiology |
5 |
|
cross infection - diagnosis - epidemiology - virology |
5 |
|
diversity |
5 |
|
dna, bacterial - chemistry - genetics |
5 |
|
dna, bacterial - genetics |
5 |
|
dna, ribosomal - analysis - genetics |
5 |
|
dog diseases - microbiology |
5 |
|
dromedary camel |
5 |
|
drug resistance, bacterial |
5 |
|
genes, rrna |
5 |
|
genetic variation - genetics |
5 |
|
genome, bacterial |
5 |
|
graft rejection |
5 |
|
immunocompromised host |
5 |
|
kidney failure, chronic - surgery |
5 |
|
kidney transplantation - adverse effects |
5 |
|
middle aged |
5 |
|
nephritis, interstitial - diagnosis - virology |
5 |
|
neutralizing antibody spike protein receptor binding domain |
5 |
|
parainfluenza virus 4, human - classification - genetics - isolation & purification |
5 |
|
phenotype |
5 |
|
polyomavirus infections - diagnosis - etiology |
5 |
|
prognosis |
5 |
|
proteobacteria - enzymology - genetics |
5 |
|
pyoderma - microbiology - veterinary |
5 |
|
renal transplant |
5 |
|
rna, ribosomal, 16s - genetics |
5 |
|
rubulavirus infections - diagnosis - epidemiology - virology |
5 |
|
sars-cov-2 n501y variant |
5 |
|
staphylococcal infections - microbiology |
5 |
|
staphylococcal skin infections - microbiology - veterinary |
5 |
|
staphylococcus - classification - genetics |
5 |
|
staphylococcus - genetics |
5 |
|
tumor virus infections - diagnosis - etiology |
5 |
|
voc |
5 |
|
adoptive transfer |
4 |
|
animal rna viruses |
4 |
|
cholangitis - microbiology |
4 |
|
cholecystitis - microbiology |
4 |
|
cloning, molecular |
4 |
|
codon - genetics |
4 |
|
computational biology |
4 |
|
conserved sequence |
4 |
|
coronavirus - genetics |
4 |
|
coronavirus hku1 |
4 |
|
covid-19 vaccine |
4 |
|
cysteine endopeptidases - metabolism |
4 |
|
cytotoxicity, immunologic |
4 |
|
dna, recombinant - administration & dosage |
4 |
|
dog |
4 |
|
dog diseases - virology |
4 |
|
glutamine |
4 |
|
hbv |
4 |
|
hepatitis b antibodies - biosynthesis - blood - immunology |
4 |
|
hepatitis b surface antigens - biosynthesis |
4 |
|
hepatitis b vaccines - administration & dosage - immunology |
4 |
|
histidine |
4 |
|
iga |
4 |
|
immune tolerance |
4 |
|
immunoglobulin g - biosynthesis - blood - immunology |
4 |
|
injections, intravenous |
4 |
|
interferon-gamma - secretion |
4 |
|
interleukin-4 - secretion |
4 |
|
lymphocyte activation |
4 |
|
macrophage |
4 |
|
macrophages, peritoneal - immunology - transplantation - virology |
4 |
|
models, molecular |
4 |
|
mucosal immunity |
4 |
|
omicron variant |
4 |
|
oral dna vaccination |
4 |
|
orf1ab |
4 |
|
picornaviridae - classification - genetics - isolation and purification |
4 |
|
picornaviridae infections - veterinary - virology |
4 |
|
picornavirus |
4 |
|
plasmids - genetics |
4 |
|
point mutation |
4 |
|
protein structure, tertiary |
4 |
|
saliva |
4 |
|
salmonella typhi - classification - genetics - isolation & purification |
4 |
|
salmonella typhimurium - genetics |
4 |
|
specific pathogen-free organisms |
4 |
|
t cell-mediated response |
4 |
|
t-lymphocytes, cytotoxic - immunology |
4 |
|
th1 cells - immunology - secretion |
4 |
|
transaminases - genetics |
4 |
|
typhoid fever - microbiology |
4 |
|
vaccination |
4 |
|
viral proteins - chemistry - genetics - metabolism |
4 |
|
ampicillin |
3 |
|
ampicillin - pharmacology |
3 |
|
anti-bacterial agents - immunology - pharmacology |
3 |
|
anti-bacterial agents - pharmacology |
3 |
|
antibodies, bacterial - biosynthesis - immunology |
3 |
|
antibodies, bacterial - blood |
3 |
|
antibody formation - drug effects |
3 |
|
antigens, bacterial - immunology |
3 |
|
antineoplastic agents, alkylating - toxicity |
3 |
|
atp-binding cassette transporters |
3 |
|
bacteremia - diagnosis - microbiology |
3 |
|
bacterial proteins - genetics |
3 |
|
bacterial vaccines - immunology |
3 |
|
blotting, southern |
3 |
|
burkholderia pseudomallei |
3 |
|
burkholderia pseudomallei - chemistry - classification - genetics |
3 |
|
burkholderia pseudomallei - genetics - immunology |
3 |
|
carrier proteins - chemistry - genetics - immunology - metabolism |
3 |
|
catheterization, central venous - adverse effects |
3 |
|
ceftriaxone - therapeutic use |
3 |
|
chromatography, high pressure liquid |
3 |
|
clarithromycin |
3 |
|
clarithromycin - immunology - pharmacology |
3 |
|
clarithromycin - pharmacology |
3 |
|
colony count, microbial |
3 |
|
cyclophosphamide |
3 |
|
cyclophosphamide - toxicity |
3 |
|
cysteine endopeptidases |
3 |
|
dna primers |
3 |
|
dna transposable elements - genetics |
3 |
|
dose-response relationship, drug |
3 |
|
endopeptidases - metabolism |
3 |
|
escherichia coli - enzymology - genetics |
3 |
|
feces - microbiology |
3 |
|
fluorogenic substrate |
3 |
|
genetic complementation test |
3 |
|
guinea pigs |
3 |
|
inflammation - prevention & control |
3 |
|
insertion sequence |
3 |
|
intestinal mucosa - drug effects |
3 |
|
isbp1 |
3 |
|
kinetics |
3 |
|
lipopolysaccharides - immunology |
3 |
|
main protease |
3 |
|
maltose-binding proteins |
3 |
|
melioidosis - diagnosis - microbiology |
3 |
|
monosaccharide transport proteins |
3 |
|
mucositis |
3 |
|
mycobacterium - classification - genetics - isolation & purification |
3 |
|
mycobacterium infections - diagnosis - microbiology |
3 |
|
neutropenia - complications |
3 |
|
penicillins - pharmacology |
3 |
|
periplasmic binding proteins |
3 |
|
polymerase chain reaction |
3 |
|
recombinant proteins - antagonists & inhibitors - metabolism |
3 |
|
salmonella enterica - immunology |
3 |
|
salmonella typhi |
3 |
|
salmonella typhi - immunology |
3 |
|
sars virus - enzymology |
3 |
|
sequence homology, nucleic acid |
3 |
|
severe acute respiratory syndrome |
3 |
|
small molecule inhibitor |
3 |
|
spectrometry, fluorescence - methods |
3 |
|
typhoid fever - drug therapy - immunology |
3 |
|
viral proteins - antagonists & inhibitors - metabolism |
3 |
|
elisa |
1 |
|
influenza a virus |
1 |
|
monoclonal antibody |
1 |
|
nonstructural protein |
1 |
